JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB17453

Anti-C3d antibody [7C10]

4

(2 Reviews)

|

(13 Publications)

Mouse Monoclonal C3 antibody. Suitable for IHC, IF and reacts with Human samples. Cited in 13 publications. Immunogen corresponding to Native Full Length Protein corresponding to Human C3.

View Alternative Names

CPAMD1, C3, Complement C3, C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1

2 Images
Immunofluorescence - Anti-C3d antibody [7C10] (AB17453)
  • IF

Supplier Data

Immunofluorescence - Anti-C3d antibody [7C10] (AB17453)

Immunofluorescent analysis of human kidney labelling C3d with ab17453 at a dilution of 1/10. Plasma of veins were stained strongly.

Immunohistochemistry - Anti-C3d antibody [7C10] (AB17453)
  • IHC

Supplier Data

Immunohistochemistry - Anti-C3d antibody [7C10] (AB17453)

Immunohistochemical analysis of human kidney labelling C3d with ab17453 at a dilution of 1/10. Plasma of veins were stained strongly.

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

7C10

Isotype

IgG1

Light chain type

kappa

Carrier free

No

Reacts with

Human

Applications

IF, IHC

applications

Immunogen

Native Full Length Protein corresponding to Human C3.

P01024

Epitope

Epitope specificity differs from that of ab17455.

Specificity

This product is specific to C3d, but also C3b and iC3b, since C3d is a product from C3b.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHC" : {"fullname" : "Immunohistochemistry", "shortname":"IHC"}, "IF" : {"fullname" : "Immunofluorescence", "shortname":"IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHC-species-checked": "testedAndGuaranteed", "IHC-species-dilution-info": "1/10", "IHC-species-notes": "<p></p>", "IF-species-checked": "testedAndGuaranteed", "IF-species-dilution-info": "1/10", "IF-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.4 Preservative: 0.098% Sodium azide Constituents: PBS, 2.9% Sodium chloride
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

C3d a fragment of the complement component C3 plays an important role in the immune response. It weighs around 35 kDa. This protein fragment forms after the cleavage of C3 and is found in the bloodstream. Researchers often refer to C3d in the context of complement activation using terms such as 'C3d complement' and 'anti-C3d-positive'. C3d is expressed extensively on cell surfaces where it binds to receptors modulating immune cell responses.
Biological function summary

The fragment plays a significant role in the regulation of immune activation processes. C3d is part of the complement system which is a complex network of proteins contributing to innate immunity. This fragment tags pathogens for destruction and acts as a bridge for enhancing adaptive immunity by linking innate and adaptive immune responses. Interaction with the complement receptor type 2 (CR2) on B cells and follicular dendritic cells is essential for its immunological function.

Pathways

C3d participates in the complement activation pathway and is an important player in the alternative pathway of complement activation. Through these pathways it is linked to proteins such as Factor B and Factor D further influencing the cascade leading to pathogen elimination. The amplification loop involving C3 and its fragments including C3d enhances the immune response emphasizing its connectivity within these pathways.

The role of C3d becomes particularly relevant in conditions like systemic lupus erythematosus (SLE) and age-related macular degeneration (AMD). Abnormal deposition of C3d and its fragments associates with inflammatory disorders such as SLE. Connection to CR2 is significant as the CR2-C3d complex can exacerbate these diseases. Understanding these interactions helps in targeting therapies for related autoimmune and inflammatory conditions.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Precursor of non-enzymatic components of the classical, alternative, lectin and GZMK complement pathways, which consist in a cascade of proteins that leads to phagocytosis and breakdown of pathogens and signaling that strengthens the adaptive immune system.. Complement C3b. Non-enzymatic component of C5 convertase (PubMed : 28264884, PubMed : 31507604, PubMed : 3653927, PubMed : 3897448). Generated following cleavage by C3 convertase, it covalently attaches to the surface of pathogens, where it acts as an opsonin that marks the surface of antigens for removal (PubMed : 28264884, PubMed : 31507604, PubMed : 3653927, PubMed : 3897448, PubMed : 833545, PubMed : 8349625). Complement C3b binds covalently via its reactive thioester, to cell surface carbohydrates or immune aggregates (PubMed : 6903192). Together with complement C4b, it then recruits the serine protease complement C2b to form the C5 convertase, which cleaves and activate C5, the next component of the complement pathways (PubMed : 12878586, PubMed : 18204047, PubMed : 2387864). In the alternative complement pathway, recruits the serine protease CFB to form the C5 convertase that cleaves and activates C5 (PubMed : 624565, PubMed : 6554279).. C3a anaphylatoxin. Mediator of local inflammatory process released following cleavage by C3 convertase (PubMed : 6968751, PubMed : 37169960, PubMed : 37852260). Acts by binding to its receptor, C3AR1, activating G protein-coupled receptor signaling, promoting the phosphorylation, ARRB2-mediated internalization and endocytosis of C3AR1 (PubMed : 8702752, PubMed : 37169960, PubMed : 37852260). C3a anaphylatoxin stimulates the activation of immune cells such as mast cells and basophilic leukocytes to release inflammation agents, such as cytokines, chemokines and histamine, which promote inflammation development (PubMed : 23383423). Also acts as potent chemoattractant for the migration of macrophages and neutrophils to the inflamed tissues, resulting in neutralization of the inflammatory triggers by multiple ways, such as phagocytosis and generation of reactive oxidants (PubMed : 23383423, PubMed : 342601, PubMed : 5778786).. Acylation stimulating protein. Adipogenic hormone that stimulates triglyceride synthesis and glucose transport in adipocytes, regulating fat storage and playing a role in postprandial triglyceride clearance (PubMed : 10432298, PubMed : 15833747, PubMed : 16333141, PubMed : 19615750, PubMed : 2909530, PubMed : 8376604, PubMed : 9059512). Appears to stimulate triglyceride synthesis via activation of the PLC, MAPK and AKT signaling pathways (PubMed : 16333141). Acts by binding to its receptor, C5AR2, activating G protein-coupled receptor signaling, promoting the phosphorylation, ARRB2-mediated internalization and endocytosis of C5AR2 (PubMed : 11773063, PubMed : 12540846, PubMed : 19615750). In contrast to C3a anaphylatoxin peptide, does not show pro-inflammatory activity (PubMed : 37852260).. C3-beta-c. Acts as a chemoattractant for neutrophils in chronic inflammation.
See full target information C3

Publications (13)

Recent publications for all applications. Explore the full list and refine your search

Journal of clinical and translational hepatology 11:540-549 PubMed36969885

2023

Fas/FasL and Complement Activation are Associated with Chronic Active Epstein-Barr Virus Hepatitis.

Applications

Unspecified application

Species

Unspecified reactive species

Jing Lin,Miao-Fang Su,Jiao-Long Zheng,Lei Gu,Hai-Cong Wu,Xia Wu,Hai-Yan Lin,Zhi-Xian Wu,Dong-Liang Li

Journal of cellular physiology 236:5012-5021 PubMed33400289

2021

Uromodulin aggravates renal tubulointerstitial injury through activation of the complement pathway in rats.

Applications

Unspecified application

Species

Unspecified reactive species

Li Yu,Fei Pei,Qiaoling Sun,Fei Shen,Xiangdong Yang,Zhao Hu,Maojing Liu

Immunity 52:167-182.e7 PubMed31883839

2019

Targeted Complement Inhibition at Synapses Prevents Microglial Synaptic Engulfment and Synapse Loss in Demyelinating Disease.

Applications

Unspecified application

Species

Unspecified reactive species

Sebastian Werneburg,Jonathan Jung,Rejani B Kunjamma,Seung-Kwon Ha,Nicholas J Luciano,Cory M Willis,Guangping Gao,Natalia P Biscola,Leif A Havton,Stephen J Crocker,Brian Popko,Daniel S Reich,Dorothy P Schafer

Frontiers in immunology 10:2209 PubMed31572401

2019

Neuropilin-1 Acts as a Receptor for Complement Split Products.

Applications

Unspecified application

Species

Unspecified reactive species

Claire Battin,Annika De Sousa Linhares,Wolfgang Paster,David E Isenman,Markus Wahrmann,Judith Leitner,Gerhard J Zlabinger,Peter Steinberger,Johannes Hofer

Nature communications 10:3656 PubMed31409793

2019

A glomerulus-on-a-chip to recapitulate the human glomerular filtration barrier.

Applications

Unspecified application

Species

Unspecified reactive species

Astgik Petrosyan,Paolo Cravedi,Valentina Villani,Andrea Angeletti,Joaquin Manrique,Alessandra Renieri,Roger E De Filippo,Laura Perin,Stefano Da Sacco

Journal of immunology (Baltimore, Md. : 1950) 201:3717-3730 PubMed30429287

2018

Complement Inhibitor CRIg/FH Ameliorates Renal Ischemia Reperfusion Injury via Activation of PI3K/AKT Signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Chao Hu,Long Li,Peipei Ding,Ling Li,Xiaowen Ge,Long Zheng,Xuanchuan Wang,Jina Wang,Weitao Zhang,Na Wang,Hongyu Gu,Fan Zhong,Ming Xu,Ruiming Rong,Tongyu Zhu,Weiguo Hu

Nature communications 9:3398 PubMed30139996

2018

Factor H binding proteins protect division septa on encapsulated Streptococcus pneumoniae against complement C3b deposition and amplification.

Applications

Unspecified application

Species

Unspecified reactive species

Anuj Pathak,Jan Bergstrand,Vicky Sender,Laura Spelmink,Marie-Stephanie Aschtgen,Sandra Muschiol,Jerker Widengren,Birgitta Henriques-Normark

Scientific reports 7:42532 PubMed28195242

2017

The alternative complement pathway is dysregulated in patients with chronic heart failure.

Applications

Unspecified application

Species

Unspecified reactive species

Negar Shahini,Annika E Michelsen,Per H Nilsson,Karin Ekholt,Lars Gullestad,Kaspar Broch,Christen P Dahl,Pål Aukrust,Thor Ueland,Tom Eirik Mollnes,Arne Yndestad,Mieke C Louwe

Proceedings of the National Academy of Sciences of 114:E534-E539 PubMed28069958

2017

Properdin binding to complement activating surfaces depends on initial C3b deposition.

Applications

Unspecified application

Species

Unspecified reactive species

Morten Harboe,Christina Johnson,Stig Nymo,Karin Ekholt,Camilla Schjalm,Julie K Lindstad,Anne Pharo,Bernt Christian Hellerud,Kristina Nilsson Ekdahl,Tom Eirik Mollnes,Per H Nilsson

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 30:2647-2652 PubMed27892735

2016

Delivery route determines the presence of immune complexes on umbilical cord erythrocytes.

Applications

Unspecified application

Species

Unspecified reactive species

Andrés de Lima,Luis C Franco,Andrés Sarmiento,John M González
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com